Public Health Alliance Warns Against Relying on RFK Jr.'s Insights on Autism

The U.S. Department of Health and Human Services (HHS) is set to unveil new information that could shed light on potential factors contributing to the increasing cases of autism spectrum disorder (ASD). However, a national coalition of health professionals and scientists, Defend Public Health, is urging caution regarding this new information.

Defend Public Health, a coalition of health professionals and scientists, is advising the public to verify any new information about ASD from the HHS with other sources. The coalition is calling for the public to exercise critical thinking when evaluating any new information about ASD from the HHS.

The upcoming information from the HHS could potentially relate to a possible link between vaccines and ASD. Any new information about a possible link between vaccines and ASD should be scrutinized carefully, according to Defend Public Health.

The HHS is expected to disclose details about interventions that could be implicated in the rising ASD rates. The interventions, as suggested by the HHS, could be contributing to the rising rates of ASD, but this information should not be accepted without question, Defend Public Health warns.

The leadership of Defend Public Health opposes the new alleged causes of ASD announced by the HHS. The coalition is urging Americans not to believe any new alleged causes for ASD announced by the HHS. Instead, they advise the public to approach any new information about ASD from the HHS with caution.

The new information from the HHS about ASD could provide insights into factors contributing to its increasing prevalence. However, Defend Public Health urges the public to verify any new information about ASD from the HHS with other sources before accepting it as fact.

Defend Public Health's warning comes as the HHS prepares to announce interventions that could be contributing to the rising rates of ASD. The public is encouraged to stay informed and to exercise critical thinking when evaluating any new information about ASD from the HHS.